Urogenital cancer
Conditions
Interventions
None listed
Sponsors
Institute for Preventive Medicine, Kurosawa Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1)Patients with newly diagnosed urogenital cancer planning invasive medical treatments including surgery, radiation therapy, chemotherapy, hormonal therapy, etc. 2)Planning those above treatments within 3 months after getting informed consent. 3)Aged between 50 and 84 years old 4)Obtain signed informed consent
Exclusion criteria
Exclusion criteria: 1)Having uncontrolled any other cancer 2)Having uncontrolled chronic disease such as diabetes mellitus, hypertension, etc. 3)Having any unacceptable conditions to participate in the present study judged by corresponding physicians
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Investigating impacts of clinicopathological features of urogenital cancers and physical status according to multiple geriatric assessments on overall survival. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1) Investigating impacts of salvage invasive treatments, oncological outcomes and longitudinal changes on physical status according to multiple geriatric assessments on overall survival. 2) Investigating impacts of changes in the physical conditions according to the scheduled multiple geriatric assessments in patients with out without physical interventions on overall survivals. 3) Investigating impacts of changes in the physical conditions from baseline to 1, 2, 3, 5 years following medical interventions on overall survivals. 4) Investigating impacts of all above affecting factors (clinicopathological features and physical conditions) issues on quality adjusted life years (QALY). | — |
Countries
Japan
Contacts
Public ContactEmi Kanai
Kurosawa Hospital Ethic committee
Outcome results
None listed